APA (7th ed.) Citation

Saura, C., Burris, H., Arteaga, C., Mayer, I., Germa, C., Fretault, N., . . . Rodon, J. (2012). 193 Phase I Safety Experience with the Oral Pan-class I PI3K Inhibitor BKM120 in Patients with Metastatic Breast Cancer (mBC). European Journal of Cancer, 48(s2), S96. https://doi.org/10.1016/S0959-8049(12)70261-7

Chicago Style (17th ed.) Citation

Saura, C., et al. "193 Phase I Safety Experience with the Oral Pan-class I PI3K Inhibitor BKM120 in Patients with Metastatic Breast Cancer (mBC)." European Journal of Cancer 48, no. s2 (2012): S96. https://doi.org/10.1016/S0959-8049(12)70261-7.

MLA (9th ed.) Citation

Saura, C., et al. "193 Phase I Safety Experience with the Oral Pan-class I PI3K Inhibitor BKM120 in Patients with Metastatic Breast Cancer (mBC)." European Journal of Cancer, vol. 48, no. s2, 2012, p. S96, https://doi.org/10.1016/S0959-8049(12)70261-7.